Drug Trial Radar · NCT02055118
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Mar 24, 2014
Primary completion
Sep 28, 2017
Study completion Sep 28, 2017
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Feb 4, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 months in pediatric patients with Hunter syndrome and cognitive impairment who have previously received and tolerated a minimum of 4 months of therapy with Elaprase.
Conditions
- Hunter Syndrome
Interventions
idursulfase-ITBiological
10mg
No IT treatmentOther
Standard of Care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Differential Ability Scales, Second Edition (DAS-II) General Conceptual Ability (GCA) Standard Score at Week 52Time frame: Baseline, Week 52
Locations
9 sites in 7 countries. Site status is shown where the registry gives one.
Children's Hospital and Research Center at Oakland
Oakland, California
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois
University of North Carolina
Chapel Hill, North Carolina
Women's and Children's Hospital, 72 King William Road
North Adelaide, Australia
The Hospital for Sick Children
Toronto, Ontario, Canada
Hôpital Femme Mère Enfant
Bron, France
Instituto Nacional de Pediatría
Coyoacán, Mexico City, Mexico
Hospital Infantil Universitario Niño Jesus
Madrid, Spain
Royal Manchester Children's Hospital
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.